← Leaderboards
Yiannis A Ioannou
Mount Sinai School Of Medicine Of Nyu
$6,438,390
Attributed
$6,438,390
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $932.3K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,438,390 · 9
By mechanism
R01$4,413,986 · 3
R21$1,855,752 · 4
R03$168,652 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsLipidsNovel StrategiesMouse ModelNerve DegenerationCholesterolCellsPhenotypeLysosomal Storage DiseasesIn VivoPathogenesisScreening ProcedureLipoidosisGenesLysosomesCell LineLipid TransportNiemann Pick DiseaseHomeostasisFutureNormal CellNeuropathologyHigh Throughput ScreeningLate Endosome
Grant awards (25)
Targeting the lysosome-mitochondria axis in neurodegenerative lysosomal storage diseases - Lessons from telomerase immortalization$169,219
R21 · FY2023 · HD · contact PI
Targeting the lysosome-mitochondria axis in neurodegenerative lysosomal storage diseases - Lessons from telomerase immortalization$295,531
R21 · FY2022 · HD · contact PI
Biomarkers for Niemann-Pick C Disease$339,653
R01 · FY2013 · DK · contact PI
Biomarkers for Niemann-Pick C Disease$351,972
R01 · FY2012 · DK · contact PI
Biomarkers for Niemann-Pick C Disease$351,972
R01 · FY2011 · DK · contact PI
HTS of Rab9 promoter activators$41,951
R03 · FY2011 · MH · contact PI
HTS of NPC1 promoter activators$41,951
R03 · FY2011 · MH · contact PI
Biomarkers for Niemann-Pick C Disease$423,750
R01 · FY2010 · DK · contact PI
Metabolomics of the Endosomal/Lysosomal System$211,875
R21 · FY2010 · NS · contact PI
Modulators of Rab9 Expression for the Treatment of Niemann-Pick C Disease$211,875
R21 · FY2010 · NS · contact PI
HTS of NPC1 promoter activators$42,375
R03 · FY2010 · MH · contact PI
HTS of Rab9 promoter activators$42,375
R03 · FY2010 · MH · contact PI
Modulators of Rab9 Expression for the Treatment of Niemann-Pick C Disease$254,250
R21 · FY2009 · NS · contact PI
Metabolomics of the Endosomal/Lysosomal System$254,250
R21 · FY2009 · NS · contact PI
Functional Characterization of the NPC Homologue NPC1L1$353,577
R01 · FY2007 · DK · contact PI
Chemical chaperones for Niemann-Pick C disease$246,877
R21 · FY2007 · DK · contact PI
Functional Characterization of the NPC Homologue NPC1L1$364,137
R01 · FY2006 · DK · contact PI
Chemical chaperones for Niemann-Pick C disease$211,875
R21 · FY2006 · DK · contact PI
Functional Characterization of the NPC Homologue NPC1L1$372,900
R01 · FY2005 · DK
Functional Characterization of the NPC Homologue NPC1L1$372,900
R01 · FY2004 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT$296,625
R01 · FY2004 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT$296,625
R01 · FY2003 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT$296,625
R01 · FY2002 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT$296,625
R01 · FY2001 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT$296,625
R01 · FY2000 · DK